Table 3

Risk subsequent muscular involvement according to aldolase at baseline after adjusting for other characteristics at baseline

Hazard ratio (95% CI)

P

Aldolase > 9 U/L

10.3 (2.3 to 45.5)

< 0.001

Age (per additional year)

0.98 (0.93 to 1.04)

0.68

Female

0.63 (0.07 to 5.18)

0.67

Diffuse form of disease

1.23 (0.27 to 5.49)

0.78

Duration of disease (per additional year)

0.97 (0.90 to 1.05)

0.57

Upper limit of plama aldolase value: 7.0 UI/L

Tolédano et al. Arthritis Research & Therapy 2012 14:R152   doi:10.1186/ar3888